Thermal treatment of a drug eluting implantable medical device
A coating and a method of coating an implantable medical device, such as a stent, is disclosed. The method includes subjecting the coating to a thermal condition which can result in reduction of the rate of release of an active agent from the coating subsequent to the implantation of the device.
1. A method of manufacturing a stent coating, comprising:
applying a composition to a stent, the composition including a polymer and a solvent;
allowing the solvent to evaporate to form a coating; and
exposing the coating to a temperature equal to or greater than the glass transition temperature of the polymer for a duration of time, wherein the polymer is a semicrystalline polymer having about 40 to 75 percent crystallinity prior to the act of exposing.
2. The method of claim 1 , wherein the composition further includes an active agent.
3. The method of claim 2 , further comprising forming a primer layer on the stent prior to applying the composition to the stent.
4. The method of claim 2 , further comprising forming a barrier layer over the coating prior to exposing the coating to the temperature.
5. The method of claim 2 , further comprising forming a barrier layer over the coating subsequent to exposing the coating to the temperature.
6. The method of claim 2 , wherein the active agent is of a type that does not adversely degrade when exposed to the temperature.
7. The method of claim 2 , wherein the act of exposing does not reduce the total content of the active agent in the coating.
8. The method of claim 2 , wherein the active agent is rapamycin, 40-O-(2-hydroxy)ethyl-rapamycin, or a functional analog or structural derivative thereof.
9. The method of claim 1 , wherein the solvent is allowed to evaporate to form a dry coating comprising less than about 2% residual fluid content (w/w).
10. The method of claim 9 , wherein the dry coating comprises less than about 1% residual fluid content (w/w).
11. The method of claim 1 , wherein the temperature is below the melting temperature of the polymer.
12. The method of claim 1 , wherein the composition additionally includes an additive for shifting the glass transition temperature or the melting temperature of the polymer to a temperature different than the actual glass transition temperature or the melting temperature of the polymer without the additive.
13. The method of claim 1 , wherein the polymer comprises an ethylene vinyl alcohol copolymer, an ethylene-vinyl acetate copolymer, poly(butylmethacrylate), or a combination of the same.
14. The method of claim 1 , wherein the temperature is equal to the glass transition temperature of the polymer plus the melting temperature of the polymer, divided by 2.
15. The method of claim 1 , wherein the temperature is equal to 0.9 times the melting temperature of the polymer, wherein the melting temperature of the polymer is expressed in Kelvin.
16. The method of claim 1 , wherein the glass transition temperature is determined by a method selected from the group consisting of dilatometry, differential thermal analysis, differential scanning calorimetry, brillouin light scattering, local thermal analysis, ellipsometry and x-ray reflectivity.
17. The method of claim 1 , wherein the polymer is a blend of two or more polymers.
18. The method of claim 1 , wherein the polymer is a block copolymer.
19. The method of claim 1 , wherein the polymer is a graft copolymer.
20. The method of claim 1 , wherein the polymer exhibits two or more glass transition temperatures, and wherein the method includes exposing the polymer to a temperature equal to or greater than the lowest exhibited glass transition temperature.
21. The method of claim 1 , wherein the polymer exhibits two or more glass transition temperatures, and wherein the method includes exposing the polymer to a temperature equal to or greater than the highest exhibited glass transition temperature.